-
Africa: WHO Recommends Accelerated Access to New Game-Changing HIV Prevention Drug
MSF, 28 July 2022
As the World Health Organization (WHO) recommended long-acting injectable cabotegravir (CAB-LA) for HIV prevention, and the Medicines Patent Pool (MPP) and UK pharmaceutical… Read more »
-
Africa: UNAIDS Welcomes ViiV's Agreement to Enable Generic Production of Long Acting PrEP to 90 Countries
UNAIDS, 28 July 2022
UNAIDS welcomes the agreement between ViiV and the Medicines Patent Pool to enable access to generic formulation of long acting Cabotegravir for PrEP to 90 low- and lower-middle… Read more »